Medanta Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Medanta stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Medanta share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Medanta stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Medanta Stock in 2026

Analyst consensus on the Medanta stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage	Rating	Medanta Stock Prediction (Rs)	Updated
JM Financial	Buy	Rs 1450	2026
ICICI Securities	Buy	Rs 1400	2026
Analyst Consensus	—	Rs 1425	2026

The Medanta stock prediction range reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Medanta stock forecast from the current price of Rs 1,230.5 may or may not be realised by end of 2026.

Medanta Company Overview

Global Health is a leading healthcare services provider operating hospitals, diagnostics or specialty facilities across India. The Medanta stock prediction for 2026 reflects structural growth in healthcare demand and operating leverage from bed expansion.

Metric	Value
NSE Ticker	MEDANTA
Sector	Healthcare Services and Hospitals
CMP	Rs 1,230.5 (2026)
52 Week High	Rs 1,456
52 Week Low	Rs 955
Market Cap	Rs 33,007 Cr
P/E Ratio	66.5
Medanta Stock Prediction Consensus (12M)	Rs 1425

Medanta Stock Prediction by Time Horizon

Analysts split the Medanta share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Medanta Stock Prediction

The near-term Medanta stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 1,230.5 are being watched closely. A short-term Medanta share price prediction carries the most uncertainty of any time horizon.

12-Month Medanta Stock Prediction

JM Financial targets Rs 1450 (Buy) and ICICI Securities targets Rs 1400 (Buy). Most desks refresh their Medanta stock forecast within two to four weeks of each quarterly earnings print. The Medanta share price prediction should be verified against the most recent analyst reports.

Long-Term Medanta Stock Prediction

The long-term Medanta stock prediction is built on assumptions about demand recovery, margin expansion and revenue diversification in the Healthcare Services and Hospitals sector. The long-term Medanta share price prediction carries the most uncertainty and should be treated as directional guidance only.

Medanta Stock Forecast: Key Factors

The following four factors appear consistently in research reports on the Medanta stock prediction and are the primary inputs into the bull and bear case scenarios.

Bed Addition and Occupancy

Hospital bed additions and occupancy rates are the primary metrics in the Medanta stock forecast. Analysts look for occupancy above 65 percent as the basis for a higher Medanta share price prediction.

Revenue per Occupied Bed

Revenue per occupied bed improvement reflects the shift to higher-margin specialties. Analysts revise the Medanta share price prediction upward when per-bed revenue grows consistently.

EBITDA Margin Maturity

A portfolio shift toward mature hospitals supports the bullish Medanta stock prediction, while new hospital ramp-ups dilute margins in the near term.

International Patient Revenue

Medical tourism revenue provides premium pricing and diversifies the revenue base, supporting the Medanta stock forecast and premium valuation.

Medanta Stock Prediction: Bull and Bear Scenarios

Scenario	Medanta Stock Prediction	Key Conditions
Bull Case	Rs 1450	Strong execution, margin improvement, favourable macro and sector re-rating
Base Case	Rs 1425	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 955	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Medanta stock forecast of Rs 1450 assumes most positive variables converge. The base case of Rs 1425 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Medanta Stock Story

Analyst reviews of the Medanta share price prediction highlight the company’s core strengths in Healthcare Services and Hospitals alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the Medanta stock prediction consensus is built on real business strengths set against real risks.

Key Risks to the Medanta Stock Prediction

New Hospital Ramp-Up Costs

New hospital investments have multi-year ramp-up periods during which margins are diluted. This is a recurring near-term risk to the Medanta stock prediction.

Regulatory and Price Cap Risk

Government-mandated price caps on medical procedures affect hospital revenues and can compress the Medanta stock forecast.

Competition

New hospital chains expanding into metro and tier 2 cities create competitive pressure on occupancy and billing, which is a recurring caution in the Medanta share price prediction.

Medical Cost Inflation

Rising manpower and consumables costs affect EBITDA margins and the Medanta stock forecast. Cost risk is reflected in the width of the Medanta share price prediction range.

How to Monitor the Medanta Stock Forecast

Track the Medanta share price prediction consensus quarterly. After every earnings release, most brokerages revise their Medanta stock forecast within two weeks. Comparing the revised Medanta stock prediction to the previous estimate tells you whether analyst sentiment is improving or deteriorating.

Compare the current price of Rs 1,230.5 with the analyst target range of Rs 1450 to Rs 1400. A wide Medanta stock prediction band reflects genuine uncertainty, so position size should reflect that range rather than the midpoint alone.

Review the Medanta share price prediction every quarter against key business metrics for the Healthcare Services and Hospitals sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Medanta Fundamentals on the Univest Screener

Conclusion

The Medanta stock prediction for 2026 reflects the analyst community’s assessment of Global Health’s competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 1450 while ICICI Securities has a Buy rating with a target of Rs 1400, giving an analyst consensus of Rs 1425.

The Medanta stock forecast is set against near-term risks that make the Medanta share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking changes in the Medanta stock prediction over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track the live Medanta stock prediction and share price prediction changes in real time.

Frequently Asked Questions on Medanta Stock Prediction 2026

What is the Medanta stock prediction for 2026?

Ans. The Medanta stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 1425. All estimates may or may not be achieved.

Is the Medanta stock prediction bullish or bearish?

Ans. JM Financial has a Buy rating with target Rs 1450. ICICI Securities has a Buy rating with target Rs 1400. The Medanta stock forecast reflects genuine analyst diversity of opinion.

What is the Medanta share price prediction based on fundamentals?

Ans. The Medanta share price prediction rests on the bed addition pipeline, occupancy trend, revenue per bed and EBITDA margin maturity. Analysts tracking Medanta closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Medanta stock prediction?

Ans. The long-term Medanta stock prediction assumes the company sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 1425 is the nearest reliable anchor point.

What are the key risks to the Medanta stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every Medanta stock prediction should be read alongside its risk assumptions.

What does the Medanta stock forecast say for 2026?

Ans. JM Financial: Buy target Rs 1450. ICICI Securities: Buy target Rs 1400. These Medanta share price prediction estimates may or may not prove accurate.

Where can I track the latest Medanta stock prediction?

Ans. Track the latest Medanta stock prediction on the NSE and BSE websites and on the Univest app and screener for live price and updated analyst targets.